Medtronic study highlights benefits of Heli-FX EndoAnchor system

Medtronic has announced new data showing how its Heli-FX EndoAnchor system can aid the treatment of patients with complex aortic abdominal aneurysm anatomies.

The findings came from a new sub-analyses from Medtronic's Anchor registry, which is evaluating the real-world applicability of the system in up to 2,000 patients.

A statistically significant difference in sac regression was observed among users of the Heli-FX system, while the device was also shown to offer additional security when used with approved endovascular stent grafts.

Patients involved in this new analysis had hostile aortic neck anatomies, which would typically make them harder to treat when using conventional therapeutic approaches.

Daveen Chopra, vice-president and general manager of Medtronic's aortic business, said: "This technology further reflects our commitment in providing solutions for challenging patients with complex aortic disease based on real-world, rigorous clinical data."

Medtronic has been in charge of distributing this product since its acquisition of Aptus Endosystems last year.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.